Stable antibodies to block SARS-CoV-2 developed

Tribune Web Desk

Updated At : 01:38 PM Jul 30, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Berlin, July 29

Researchers have developed highly potent and stable antibodies from the blood of alpacas which can efficiently block SARS-CoV-2, the virus that causes Covid-19, and its dangerous new variants.

The researchers from the Max Planck Institute (MPI) for Biophysical Chemistry in Germany noted that these mini-antibodies bind and neutralise the virus up to 1,000 times better than previously developed such antibodies. In the study published in The EMBO Journal, the researchers optimised the so called nanobodies for stability and resistance to extreme heat. — PTI

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles